台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    63.9
  • 漲跌
    ▲0.1
  • 漲幅
    +0.16%
  • 成交量
    37
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-群益金鼎-台北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-台北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/2100.00164.0063.90-1148-0.67%
2024/11/19265.40164.0063.8011460.68%
2024/10/1400.00164.9065.70-1160-0.62%
2024/10/09263.25163.2062.2011530.65%
2024/10/0800.00165.5063.20-1150-0.67%
2024/09/30159.6000.0059.2011370.72%
2024/08/0900.00057.0056.200203-0.01%
2024/08/08056.4000.0056.2002010.01%
2024/07/3000.00263.6066.20-2231-0.86%
2024/07/29263.9000.0066.6022190.91%
2024/06/28170.20169.4069.7002290.00%
2024/06/25170.30168.2068.3002270.00%
2024/06/24167.40267.4068.50-1225-0.44%
2024/06/20164.70265.7064.70-1222-0.45%
2024/06/1800.00263.9564.40-2220-0.91%
2024/06/1700.00163.4063.40-1219-0.45%
2024/06/14263.9500.0063.5022190.91%
2024/06/13264.7000.0064.0022190.91%
2024/06/11167.50166.8066.7002170.00%
2024/06/07366.97266.6566.3012170.46%
2024/06/06267.20267.2067.1002170.00%
2024/06/04164.30163.2063.3002140.00%
2024/06/03164.80164.5064.9002220.00%
2024/05/21168.30166.0066.3002890.00%
2024/05/20167.00167.9067.9003070.00%
2024/05/17166.00166.1066.1003060.00%
2024/05/16164.70165.7065.9003070.00%
2024/05/15166.50165.2065.2003210.00%
2024/05/14166.00165.6065.6003230.00%
2024/05/13166.30164.3064.3003220.00%
2024/05/10166.70167.8066.0003190.00%
2024/05/09367.10366.9067.1003130.00%
2024/05/08264.30264.7064.4002990.00%
2024/05/07162.10162.5062.3002840.00%
2024/05/06161.00160.2060.4002730.00%
2024/05/02159.40160.5060.5002680.00%
2024/04/26160.60160.2060.3002630.00%
2024/04/23460.80460.7560.7002550.00%
2024/03/0700.00157.0056.60-1245-0.41%
2024/03/0500.00161.2061.20-1228-0.44%
2024/03/04165.00161.2061.1002260.00%
2024/03/01365.17163.8063.8022200.91%
2024/02/29164.00362.9763.60-2220-0.91%
2024/02/27261.75264.9064.3002160.00%
2024/02/26161.70161.1061.2002050.00%
2024/02/23561.56360.7061.0022020.99%
2024/02/22261.25460.3560.00-2193-1.03%
2024/02/20256.65156.2056.3011630.61%
2024/02/19257.05156.1056.0011610.62%
2023/12/26151.60151.7050.4004110.00%
2023/11/021152.961151.0851.0001160.00%
2023/10/30449.60449.6648.700540.00%
2023/07/31148.85148.7548.400750.00%
2023/07/20149.65149.1048.300650.00%
2023/07/19147.50150.2049.850620.00%
2023/07/12246.88246.5546.550430.00%
2023/03/142046.542048.3148.500740.00%
2022/08/0900.00142.6542.45-1164-0.61%
2022/08/02146.4000.0044.6011530.65%
2021/10/25147.35148.4547.500800.00%
2021/10/21147.50147.7545.300690.00%
2020/08/2800.00164.2064.60-1103-0.97%
2020/08/2600.00263.8063.30-2108-1.85%
2020/08/20163.1000.0063.0011170.85%
2020/08/18163.9000.0064.4011170.85%
2020/08/1400.00264.8064.40-2116-1.72%
2020/08/13164.1000.0064.3011150.86%
2020/08/11164.1000.0064.5011160.86%
2020/08/06165.1000.0064.6011170.85%
2019/09/2500.00179.9079.60-141-2.41%
2019/08/2800.00179.7079.80-141-2.44%
2019/08/2100.00174.2074.70-140-2.46%
2019/08/1300.00178.6079.10-142-2.38%
2019/08/12178.8000.0079.501412.42%
2019/08/05174.00174.8074.800360.00%
2019/05/2300.00267.4067.10-244-4.52%
2019/05/09265.1000.0065.202543.66%
2019/05/03366.1000.0066.403614.86%
2018/10/19182.50178.5078.5001330.00%
2018/08/23188.50286.3586.30-1174-0.57%
2018/08/21187.80188.1088.1001740.00%
2018/08/20186.8000.0086.7011730.58%
2018/08/17188.60185.4084.8001730.00%
2018/08/1600.00187.9087.90-1171-0.58%
2018/08/09188.3000.0091.3011610.62%
2018/08/0800.00187.9084.80-1155-0.64%
2018/08/03189.60188.5089.2001500.00%
2018/08/01187.4000.0089.2011480.67%
2018/04/2600.00491.2389.00-4409-0.98%
2018/04/25490.0000.0090.0043841.04%
2018/04/23292.00988.4993.80-7298-2.35%
2018/04/20785.3000.0085.3072752.55%
2018/04/1900.00685.4586.90-6266-2.25%
2018/04/18684.7000.0084.7062532.37%
2018/04/1000.00378.8076.80-3201-1.49%
2018/04/09377.80476.1077.80-1193-0.52%
2018/04/03475.40577.7075.40-1187-0.53%
2018/04/02576.7000.0076.7051782.80%
2018/01/1700.00166.7065.10-177-1.28%
2018/01/08157.3000.0056.801581.71%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章